© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Flufenamic acid’s story started in the mid-1960s, coming out of a period when drug research chased better pain relief. Folks back then faced all kinds of aches, so labs searched for compounds that could calm things down without the heavy side effects seen with older painkillers. Derived from the fenamate class, flufenamic acid offered a new take for both chronic and acute pain, especially with its anti-inflammatory punch. By the late 1960s, it hit the market mainly for pain related to arthritis. Doctors saw it as progress because it could go up against aspirin but offered different benefits and risks. Yet as newer drugs entered the race—think indomethacin and ibuprofen—flufenamic acid didn’t grab much of the spotlight in North America, though some places in Europe and Asia stuck with it a little longer.
Flufenamic acid stands out as a white or nearly white crystalline powder. Structurally, it boasts a fenamate backbone with a trifluoromethyl group tacked onto one of its aromatic rings. This trifluoromethyl group seems small but changes how the drug is absorbed and acts in the body. Flufenamic acid’s formula, C14H10F3NO2, sits at a molecular weight of 281.23 g/mol. Its melting point lands right around 130°C, and it’s pretty stubborn when asked to dissolve in water, preferring organic solvents like ethanol or chloroform. The compound’s lipophilicity shapes its journey through the body, affecting both how long it sticks around and how it gets broken down.
If you examine the technical side, purity levels matter. Medical-grade flufenamic acid should clock in at above 99% purity, with limits set for moisture and identifiable impurities. Labeling usually needs to spell out the manufacturer, batch number, and expiration, keeping health regulators in the loop about quality and traceability. Its crystalline form also matters—different crystal structures can influence both shelf life and how well it mixes with other tablet ingredients. Good labeling practice, combined with strong supply chain oversight, keeps patients safer and gives doctors peace of mind when picking a pain reliever.
Getting to flufenamic acid starts with the classic reaction of anthranilic acid and 3-trifluoromethyl aniline. Chemists bring these together using reagents like phosphorus trichloride or thionyl chloride to link the pieces into an amide. The reaction produces a solid that usually needs to be recrystallized for higher purity. Over time, labs tried tweaks—substituting groups or shifting the assembly—looking for even safer or stronger drugs. Some researchers tried to generate derivatives with altered side chains, hoping for more targeted pain or inflammation relief, or to curb stomach irritation, which remains the Achilles’ heel of many NSAIDs.
Outside chemistry circles, you can hear flufenamic acid called flufenamate or by brand names that survive in international markets. Its chemical name, N-(3-trifluoromethylphenyl)anthranilic acid, rarely lands on a pharmacy bottle but matters for research and regulation. Even with different labels, pharmacists and chemists rely on structural diagrams and CAS numbers to sort flufenamic acid from its cousins in the lab.
Using flufenamic acid, like any NSAID, means keeping an eye on the risk of stomach ulcers, bleeding, or kidney issues. These hazards drove much of the regulatory action around the drug, mandating stricter warnings. Manufacturing settings follow guidelines for dust control and personal protection. If handled in labs or plants without basic gloves and fume hoods, workers risk headaches and respiratory irritation. Safe disposal also requires care; improper dumping could disrupt local waterways, since traces of these drugs can harm aquatic life. Workers in the industry learn respect for these substances, not just on paper but from stories passed down about spills and close calls.
Medical textbooks group flufenamic acid with the fenamates, mainly for short-term pain and inflammation relief tied to muscles, joints, or menstruation. It doesn’t fly off pharmacy shelves like some newer drugs, but researchers keep it in their sights as a kind of reference standard for evaluating new anti-inflammatories. Outside pain clinics, some labs in Asia and Africa investigate it for use in veterinary medicine or as a chemical tool in biochemistry studies. You also find it in experiments probing ion channel activity or testing hypotheses about cell signaling. This kind of cross-disciplinary use sometimes gets overlooked in big pharmaceutical histories.
Researchers dug into the toxicity of flufenamic acid, especially looking for patterns in gastrointestinal or renal side effects. Studies with lab animals traced how flufenamic acid interacts with cyclooxygenase enzymes, much like aspirin or ibuprofen. Real-world cases link extended or high-dose use with bleeding and gastrointestinal irritation, pressing doctors to check kidney function if patients use it long-term. Scientists also track its behavior in cells, since flufenamic acid blocks specific ion channels and may play a role in epilepsy research. Some labs explore its anti-cancer properties, though work remains early. Flufenamic acid’s raw chemistry makes it a springboard for developing fresh drugs, and some hope new derivatives can sidestep problems that limited its adoption in Western medicine. There’s current interest in nano-formulations to enhance absorption and reduce side effects, and some groups think the molecule’s structure could inform a new generation of personalized pain relievers.
Even as flufenamic acid fades from center stage in some regions, the curiosity it inspires hasn’t dimmed. Its chemical backbone keeps popping up in new research as scientists hunt for more precise enzyme blockers or less toxic anti-inflammatories. With synthetic chemistry moving at a fast clip, future tweaks could turn lessons learned from flufenamic acid’s strengths and weaknesses into new treatments for pain, inflammation, or even neurological disorders. Until new options prove themselves, the flufenamic acid story reminds us how each step in drug design opens up both promise and caution, and how every “old” drug still has lessons for the next generation of researchers and doctors.
Flufenamic acid hasn’t landed on many household medicine shelves, though it belongs to a family of medicines known as nonsteroidal anti-inflammatory drugs (NSAIDs). In the world of chemistry, it shares the stage with familiar names like ibuprofen and diclofenac. Back in the 1960s, scientists started looking at flufenamic acid to manage pain, swelling, and fever. While other NSAIDs took the spotlight, flufenamic acid settled in quieter medical corners.
Doctors and pharmacists sometimes use flufenamic acid to treat arthritis pain, menstrual cramps, and occasionally other types of discomfort. It works by blocking enzymes (COX-1 and COX-2) that help create substances in the body, called prostaglandins, which trigger pain and inflammation. People experiencing joint pain or sore muscles often feel relief after taking NSAIDs like these. This can make a huge difference for someone trying to get through a tough workday with an aching shoulder or for those coping with the stiffness that arthritis brings.
While big pharma companies have steered public attention toward better-known painkillers, flufenamic acid still finds use in countries across Asia, the Middle East, and parts of Europe. Access often depends on local guidelines and the habits of doctors in those areas. In recent years, more attention has returned to older drugs like flufenamic acid, partly because some people don’t respond well to common over-the-counter options.
Anyone who’s ever found relief with an NSAID probably knows there’s a tradeoff. Flufenamic acid can irritate the stomach, sometimes causing pain, indigestion, or even bleeds—especially after long-term use. People with a history of ulcers or gastrointestinal trouble might find themselves worse off if they don’t speak up about previous stomach issues. For older folks, or those dealing with chronic illnesses, mixing several medications can turn stomach upsets into something much more serious. It's not rare to encounter warnings about kidney or liver troubles, especially if the drug finds its way into daily routines without careful oversight.
Doctors and pharmacists can help sort out which medication best fits each person’s story, but easy solutions rarely exist. Not every pain medication fits every person, and flufenamic acid sits in a tricky place—it sometimes works when others don’t, but it won’t suit everyone.
Communities facing limited access to widely marketed drugs may still rely on flufenamic acid, but differences in how medicines are regulated can shape what people use. Countries with stricter drug approval processes now stick mainly to NSAIDs with a stronger track record in large studies. Still, interest in flufenamic acid hasn’t faded completely, especially as researchers investigate whether it has a place beyond pain: looking at rare diseases, certain cancers, or even as a building block for new medicines.
The story of flufenamic acid goes far beyond a simple prescription. Doctors, based on experience and up-to-date guidelines, weigh the risks, talk with patients about what has worked before, and pay close attention to what doesn’t. People facing persistent pain want options. Every tool, old or new, can matter in that journey.
Flufenamic acid turns up in pain clinics and some family medicine cabinets. Doctors hand it out to treat inflammation, swelling, and fever, often in people fighting arthritis or period pain. This medicine comes from the fenamate class of nonsteroidal anti-inflammatory drugs (NSAIDs), which means folks expect results but also should expect a few bumps along the way.
Stomach pain and nausea come up for a reason. The gut lining doesn’t get along well with drugs like this. Some people feel queasy or bloated. Others rush to the bathroom more often, dealing with indigestion or, worse, diarrhea. It’s rare, but a stomach ulcer may appear, especially after weeks or months of repeat dosing. Any sign of black or bloody stools, or vomiting something that looks like coffee grounds, screams for a quick doctor’s visit. Most worries fade with food in the stomach before swallowing a pill, but eating a cracker doesn’t always save the day.
NSAIDs don’t just pick on the stomach. They can crowd the kidneys and slow how well they filter. People with kidney disease or low blood flow run a real risk here. Watch for swollen ankles, fatigue, or urine changes—these hint the kidneys are getting overwhelmed. Liver checks matter, too, especially with skin yellowing, relentless fatigue, or itchiness. Risks climb with age, longer treatment, or pairing with other medicines that weigh heavy on these organs. Regular blood panels with the family doctor serve as early warning systems.
People glow red or break out in hives after swallowing the drug. This isn’t just an annoyance—breathing trouble, tongues swelling, and rashes turning purple call for emergency care. Children and the elderly react more strongly, though nobody is fully in the clear. My neighbor tried flufenamic acid for a stubborn ankle sprain; his arms broke out in itchy red welts by dinner. He needed antihistamines for days and learned the hard way that unexpected reactions demand attention.
Blood pressure can bump up. Retention of fluid sneaks in, especially in older folks. Some people notice the swelling first in their feet or hands. Extra pressure on the heart raises risk, especially for anyone who already manages blood pressure with pills or has a diagnosis of heart failure. In the U.K., after long-term NSAID use, more patients get checked for blood pressure jumps. Simple home monitors catch these early on if the medicine becomes a regular thing.
Doctors don’t pull flufenamic acid out right away. Small adjustments—lower doses, food in the stomach, or rotating with other painkillers—help. Blood pressure, kidney, and liver labs make up the toolkit for people at higher risk. Pharmacists suggest tracking new symptoms in a notebook and always telling doctors about every pill in the cabinet, prescribed or over-the-counter. For pain relief without pills, ice packs, gentle exercise, or physical therapy lower reliance on NSAIDs. Patients who stay in touch with their doctor and watch for side effects have the best shot at feeling better without bigger problems down the line.
Most folks don’t walk into a pharmacy and run into flufenamic acid. It’s not a household name like ibuprofen. Flufenamic acid falls under the fenamate class of medicines, used as painkillers and anti-inflammatories for arthritis and some other aches. Over the years, people have asked if they can pick it up like paracetamol or if there’s that extra hurdle: the doctor’s slip.
Pharmacists and regulators look at medicines pretty closely before letting anyone take them straight from the shelf. Flufenamic acid has a history that explains the rules. It works by cooling down inflammation in the body, but it didn’t reach the same popularity as other painkillers. Part of the reason comes from its side effects. Nausea, gastric ulcers, even headaches—not exactly a walk in the park. Reports have shown stronger safety risks when used without proper guidance, especially for people who already struggle with ulcers or heartburn.
In places like the UK and US, regulatory agencies rarely allow nonsteroidal anti-inflammatory drugs (NSAIDs) of this kind to go prescription-free. Europe mostly feels the same—it’s rare to see this drug in an over-the-counter setup. I’ve never seen it sitting out next to aspirin in any pharmacy I’ve visited or worked with. Many countries only allow flufenamic acid with a doctor’s prescription. That means a real consultation, a look at your health history, and a careful check for interactions or allergies. For folks who like to skip the clinic and search online, finding high-quality, legal options isn’t easy.
Some will argue the rules are too strict and limit options for people who need pain relief. Others, including doctors I know, see the prescription as a kind of safety net. They’ve seen patients damaged by careless use of NSAIDS—sometimes it starts as a small stomach pain and ends up as a bleeding ulcer. Given these stories, plain access lifts risk. It’s not just official bureaucracy at play—there’s a real-life cost to skipping those checks and balances.
It helps to picture what happens if flufenamic acid becomes a walk-up purchase at your nearest drugstore. Kids, older adults, people with compromised kidneys, or anyone taking blood thinners could reach for a “stronger painkiller” with little warning about new risks. Side effects aren’t just footnotes—they impact lives and hospital rooms fill up with stories like this every year.
Some countries update their lists as evidence grows. They consider both the benefit of a new drug and the cost that shows up in real people’s lives. Robust pharmacist oversight, mobile health checkups, or clearer warning labels may help those who need quicker solutions—without swinging the door wide open.
Pharmacists have told me they feel more pressure than ever to deliver both safety and convenience. Training on the less-common painkillers, built-in protocols, and accessible online information—for experts and patients—build knowledge and confidence.
Ask a doctor or pharmacist if you’re curious about alternatives. They’ll take into account long-term health, your other medications, and your pain story. If safety guides the process, trust follows. That’s what makes a strong healthcare system and keeps ERs from seeing those “it started with a tablet” cases.
Flufenamic acid doesn’t make headlines like the latest wonder drugs, but plenty of people have run into it over the years, mostly through old prescriptions for pain and swelling. It belongs to a group called nonsteroidal anti-inflammatory drugs, or NSAIDs. You’d actually spot it more often in some European and Asian pharmacies, but doctors everywhere know what it’s meant to do: knock down inflammation, help manage pain, and sometimes lower fevers. When thinking about using flufenamic acid, smart advice starts with a visit to someone who understands its effects—usually a doctor or a pharmacist.
Most folks take flufenamic acid in tablet form. The point is to let your gut absorb it and allow the drug to enter your bloodstream. Healthy adults usually get advice to swallow the pill whole with some water, either during or after meals. Eating beforehand really makes a difference; this isn’t just another take-on-empty-stomach pill. NSAIDs can hit the stomach lining hard—anyone who's wrestled with indigestion or ulcers knows how miserable that gets. Food creates a buffer and lowers the risk of tummy trouble or even bleeding ulcers.
Doctors rarely hand out flufenamic acid to anyone with a mild headache, but if they do reach for it, careful dosing is part of the deal. It makes no sense to double up for faster relief—people have landed in emergency rooms with liver and kidney damage by thinking more is better. Typical adult doses fall between 200mg and 300mg, up to three times a day, but even within that range, doctors will make adjustments based on the patient’s health history, age, and other medications. Those who live with chronic illness or take several medicines need extra attention, since drug interactions spell real trouble with NSAIDs. Anyone who’s got a history of kidney issues, stomach ulcers, or bleeding disorders should speak up before starting the drug. Kids rarely get flufenamic acid, unless it's a decision made by a specialist with clear reasons.
Everyone forgets a dose sooner or later. The usual advice: take the pill as soon as it pops into your head, unless it’s close to time for the next one. Stacking doses amplifies the risk of side effects like stomach pain, heartburn, or worse. Stopping abruptly won’t usually cause withdrawal, but it may let pain or swelling return. It’s smart to stick to the plan and keep your doctor in the loop about side effects, even if they seem minor—the earlier you spot trouble, the easier it is to fix it.
Every NSAID comes with a list of side effects, and flufenamic acid is no different. Gut problems top the list, but there’s more. Long-term use or heavy dosing ups the chances of kidney problems, high blood pressure, and sometimes skin rashes. Anyone with a past allergy to other NSAIDs, like aspirin, should steer clear. Even for those who haven’t had problems before, symptoms like sudden swelling, trouble breathing, or chest pain mean turning off autopilot and getting urgent help. Those taking flufenamic acid for more than a week or two need periodic check-ins—blood tests and blood pressure checks help spot damage before it gets serious.
Flufenamic acid has a long track record, but today’s doctors weigh its risks against proven alternatives. Sometimes they’ll recommend it for very specific pain problems, or in countries where options are limited. Where possible, updating to newer NSAIDs or exploring non-drug therapies—like targeted exercise, mindfulness, or physical therapy—takes priority. Less medicine, more teamwork between patient and prescriber: that leads to safer outcomes, fewer complications, and a better handle on daily pain. Smart use comes down to listening, learning, and never being afraid to ask for a second opinion.
Flufenamic acid belongs to the family of nonsteroidal anti-inflammatory drugs, or NSAIDs. It’s been around since the 1960s, mainly used to deal with pain and inflammation. Plenty of folks look to NSAIDs for relief, especially for muscle aches, arthritis, or menstrual discomfort. But with any medicine, side effects and risk come along for the ride. The bigger issue now sits with how this drug might butt heads with other pills in daily life.
People often juggle more than one prescription, so checking for drug interactions matters. With flufenamic acid, certain combinations raise red flags. For example, mixing it with anticoagulants like warfarin raises the risk of bleeding. NSAIDs slow the formation of blood clots, so anyone taking blood thinners should watch out. Even a small injury could become a bigger problem.
Another concern pops up when flufenamic acid meets other anti-inflammatory medications, such as aspirin or ibuprofen. Taking multiple NSAIDs at once won’t offer extra relief, but it does ramp up the chance of stomach ulcers, bleeding, and kidney problems. As someone who’s seen friends struggle with chronic pain, I know how tempting it gets to double up when pain becomes unbearable. Sadly, that shortcut can land people in the hospital.
People with high blood pressure should keep watch too. Combining NSAIDs like flufenamic acid with ACE inhibitors or diuretics (water pills) used for treating hypertension can blunt the effect of those drugs. Blood pressure creeps back up and kidney function can take a hit. Regular check-ups give a clearer picture if this combo becomes routine.
Flufenamic acid also messes with lithium levels. Used for bipolar disorder, lithium works in a tight window between helpful and toxic. NSAIDs can boost lithium concentration in the blood. That side effect can bring on tremors, confusion, and in some cases, organ damage. For anyone balancing mental health and pain, routine blood tests and honest doctor-patient talk build a safer path forward.
Drugs sitting on pharmacy shelves might seem harmless. Reality looks different. Even herbal supplements like ginkgo can add to bleeding risk when mixed with NSAIDs. St. John’s Wort can affect how the body breaks down medications, throwing off intended results. Anybody who’s walked down the supplement aisle knows how overwhelming those choices can be. It doesn’t hurt to ask a pharmacist or doctor for a double-check.
Pharmacists hold a treasure trove of knowledge about drug interactions. Sharing a full medication list with them creates a safety net. Tools like online medication checkers offer extra eyes, but they don’t replace expert advice. Changing or adding drugs without telling the healthcare team makes things riskier than most realize.
Side effects sneak up silently, but paying attention to warning signs—like new bruising, trouble breathing, or stomach pain—makes a difference. Keeping all prescribed and over-the-counter drugs in one spot, logged in a notebook or on a phone, turns visits with healthcare providers into productive sessions instead of guessing games.
Safety comes down to honest talk and steady follow-up. Flufenamic acid, like any drug, works better with partnership and awareness. Blending trust with up-to-date medical facts creates more good days and fewer surprises.
| Names | |
| Preferred IUPAC name | N-(3-(trifluoromethyl)phenyl)anthranilic acid |
| Other names |
Afiamon Flufenam Meclomen Proquanon Rheumon Seclodin Flufenamicum |
| Pronunciation | /fluːˌfɛnəˈmɪk ˈæsɪd/ |
| Identifiers | |
| CAS Number | 530-78-9 |
| Beilstein Reference | 54827 |
| ChEBI | CHEBI:5104 |
| ChEMBL | CHEMBL1419 |
| ChemSpider | 7146 |
| DrugBank | DB02262 |
| ECHA InfoCard | 100.018.837 |
| EC Number | EC 211-581-2 |
| Gmelin Reference | 77452 |
| KEGG | C06984 |
| MeSH | D005473 |
| PubChem CID | 3365 |
| RTECS number | MF1150000 |
| UNII | 8SKN0B0MIM |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C14H10F3NO2 |
| Molar mass | 281.24 g/mol |
| Appearance | White to almost white crystalline powder |
| Odor | Odorless |
| Density | 1.264 g/cm³ |
| Solubility in water | Very slightly soluble in water |
| log P | 4.8 |
| Vapor pressure | 4.63E-8 mmHg at 25°C |
| Acidity (pKa) | 4.2 |
| Basicity (pKb) | pKb = 11.77 |
| Magnetic susceptibility (χ) | -62.0·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.672 |
| Viscosity | Viscous oil |
| Dipole moment | 3.02 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 309.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -128.8 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -6311 kJ/mol |
| Pharmacology | |
| ATC code | M01AG03 |
| Hazards | |
| Main hazards | Harmful if swallowed, causes skin and eye irritation, may cause respiratory irritation. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 + H312 + H332: Harmful if swallowed, in contact with skin or if inhaled. |
| Precautionary statements | P261-P262-P264-P270-P271-P301+P312-P305+P351+P338-P330 |
| Flash point | 254.6°C |
| Autoignition temperature | 400°C |
| Lethal dose or concentration | LD50 rat oral 446 mg/kg |
| LD50 (median dose) | LD50: 496 mg/kg (oral, rat) |
| NIOSH | MF7950000 |
| PEL (Permissible) | PEL: Not established |
| REL (Recommended) | 500 mg daily |
| IDLH (Immediate danger) | Not listed |
| Related compounds | |
| Related compounds |
Mefenamic acid Meclofenamic acid Tolfenamic acid Niflumic acid Clonixin |
